Table 2.
Potential future stream of demand for revision from primary procedures
| Uptake level | 2022–2023 | 2023–2024 | 2024–2025 | 2025–2026 | 2026–2027 | 2027–2028 | 2028–2029 | 2029–2030 |
|---|---|---|---|---|---|---|---|---|
| Scenario 1: newly eligible patients only | ||||||||
| 20% | 637 | 655 | 674 | 693 | 713 | 733 | 754 | 776 |
| 35% | 1,114 | 1,146 | 1,179 | 1,213 | 1,247 | 1,283 | 1,320 | 1,358 |
| 75% | 2,388 | 2,456 | 2,526 | 2,599 | 2,673 | 2,750 | 2,829 | 2,910 |
| Scenario 2: existing patients only — assumes a 5-year program to treat all existing (2019–2020) eligible patients | ||||||||
| 20% | 4,448 | 4,448 | 4,448 | 4,448 | 4,448 | - | - | - |
| 35% | 7,785 | 7,785 | 7,785 | 7,785 | 7,785 | - | - | - |
| 75% | 16,681 | 16,681 | 16,681 | 16,681 | 16,681 | - | - | - |
| Scenario 3: treating new eligible patients and a 5-year program to treat existing eligible patients (as of 2019–2020) | ||||||||
| 20% | 5,085 | 5,103 | 5,122 | 5,141 | 5,161 | 733 | 754 | 776 |
| 35% | 8,899 | 8,931 | 8,964 | 8,997 | 9,032 | 1,283 | 1,320 | 1,358 |
| 75% | 19,069 | 19,138 | 19,208 | 19,280 | 19,354 | 2,750 | 2,829 | 2,910 |
“-” not applicable